Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study

Related Experiment Videos

Weiquan Lu1, Helaine E Resnick, Kathleen A Jablonski

  • 1MedStar Research Institute and Washington Hospital Center, Washington, DC., USA.

Diabetes Care
|December 28, 2002
PubMed

Insights

Non-high-density lipoprotein (HDL) cholesterol strongly predicts cardiovascular disease (CVD) in individuals with diabetes. This lipid measure is particularly useful for identifying coronary event risk in this population.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Lipid Metabolism

Background:

  • Diabetes mellitus is a significant risk factor for cardiovascular disease (CVD).
  • Traditional lipid profiles may not fully capture CVD risk in diabetic patients.
  • Non-high-density lipoprotein (non-HDL) cholesterol offers a comprehensive measure of atherogenic lipoproteins.

Purpose of the Study:

  • To investigate the predictive value of non-HDL cholesterol for incident CVD in patients with diabetes.
  • To compare the predictive power of non-HDL cholesterol against other lipid parameters.

Main Methods:

  • Utilized data from the Strong Heart Study, a population-based cohort of American Indian adults aged 45-74 years.
  • Included 2,108 participants with diabetes and no baseline CVD, followed for an average of 9 years.
  • Employed multivariable analyses to assess the association between non-HDL cholesterol and CVD events.

Main Results:

  • Non-HDL cholesterol was a significant predictor of both fatal and nonfatal CVD in men and women with diabetes.
  • Higher non-HDL cholesterol levels were particularly associated with an increased risk of coronary events.
  • Non-HDL cholesterol demonstrated superior predictive utility compared to LDL cholesterol, triglycerides, or total/HDL cholesterol ratio in certain analyses.

Conclusions:

  • Non-HDL cholesterol is a valuable biomarker for assessing CVD risk in diabetic individuals.
  • This lipid metric may enhance cardiovascular risk stratification in diabetes management.
  • The predictive utility of non-HDL cholesterol is robust across various triglyceride concentrations.
Abstract

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...